Related Experiment Video
Updated: Jan 31, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Health Councils and Pharmaceutical Policy: Challenges and prospects for social participation in Brazil
Fernanda Manzini1, Luisa Arueira Chaves2, Vinícius André Boff1
1Programa de Pós-Graduação em Assistência Farmacêutica, Universidade Federal de Santa Catarina. R. Delfino Conti s/n, Trindade. 88040-370 Florianópolis SC Brasil. manzinifer@gmail.com.
Abstract:
The National Pharmaceutical Policy (PNAF) originated from social participation, making its role in monitoring and addressing issues related to this policy essential. In this context, this article aims to identify and analyze how the Pharmaceutical Policy (PP) (considering access to medicines and pharmaceutical services) have been addressed and discussed in the Brazilian Health Councils from 2019 to 2021. It was conducted a quantitative and qualitative documentary analysis of documents from all the states (including the Federal District) and municipal councils in the Brazilian capitals. It was identified 806 excerpts referencing the PNAF, of which 186 excerpts were included in the thematic analysis. These excerpts were organized into eight analytical categories, indicating that while PP is a contemporary topic in the councils and gained prominence and qualification during the COVID-19 pandemic, there are still gaps in the discussion, particularly regarding service organization. The development of appropriate tools for monitoring and evaluating the PNAF, ongoing training for council members, and investment in dedicated committees are highlighted as key elements for advancing the role of social participation at all health organization levels.
Related Concept Videos
Social Traps
Social Proof
Social Scripts
Pharmaceutical Equivalents
Social Facilitation
Social Loafing

